5P5-79251-92446
3 vaccinations
7 coded responses
39 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 662 / KS
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
- 2021-03-30
-
2021-03-31
Survey response — days 1–6 daily, dose 1MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Bad taste in my mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, NauseaAdult check-in
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
-
2021-04-20
Dose 2 — Pfizer-BioNTech
- 2021-04-20
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-04-23
-
2021-04-24
Survey response — days 1–6 daily, dose 2MedDRA: Menstruation delayed — Feeling: GoodFree text: Menstruation four days lateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-07-20
- 2021-10-19
-
2021-10-22
Dose 3 — Pfizer-BioNTech
- 2021-10-22
-
2021-10-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-24
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Poor · Site: Pain · Headache, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Swollen, painful lymph node under left armMedDRA releases: 2024-11 · check-in free text available
-
2021-10-25
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy, Pain — Feeling: Fair · Site: Pain · Muscle or body achesFree text: Pain and swelling in underarm lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Muscle or body achesFree text: Swollen, painful lymph node under armMedDRA releases: 2024-11 · check-in free text available
-
2021-10-27
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Muscle or body achesFree text: Lymph node under arm swollen and mildly painfulMedDRA releases: 2024-11 · check-in free text available
- 2021-10-28
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2022-01-21
- 2022-04-22
-
2022-10-24
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-10-22 | Pfizer-BioNTech | No |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Bad taste in my mouth
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Menstruation four days late
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen, painful lymph node under left arm
Systemic reaction (other): Pain and swelling in underarm lymph node
Systemic reaction (other): Swollen, painful lymph node under arm
Systemic reaction (other): Lymph node under arm swollen and mildly painful
Release 12 — 12 months, dose 3
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Menstruation delayed | ✓ | ✓ | ✓ |
| SRO | Pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release